<DOC>
	<DOCNO>NCT00435058</DOCNO>
	<brief_summary>During glaucomatous disease process , subpopulation cell may dead , damage healthy . Visual function change could observe due recover suffer ganglion cell intraocular pressure reduction . This study aim evaluate correlation intraocular pressure reduction visual function change glaucoma patient use antiglaucoma medication .</brief_summary>
	<brief_title>Visual Function Changes After Intraocular Pressure Reduction</brief_title>
	<detailed_description>Primary open angle glaucoma patient without use antiglaucoma medication enrol study . After inclusion , patient randomly receive one three antiglaucoma medication ( timolol maleate 0,5 % , brimonidine tartrate 0,2 % travoprost 0,004 % ) one randomly select eye . The patient evaluate Goldmann applanation tonometry , visual acuity test , contrast sensitivity test , visual quality perception test ( visual analogue scale ) standard automate perimetry 4 week glaucoma treatment onset .</detailed_description>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>Primary open angle glaucoma Intraocular pressure great 21 mmHg Best correct visual acuity ( BCVA ) worse 20/80 Significant medium opacity History steroid use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>intraocular pressure</keyword>
	<keyword>contrast sensitivity</keyword>
	<keyword>visual function</keyword>
</DOC>